Nell Greenfieldboyce

Nell Greenfieldboyce is a NPR science correspondent.

With reporting focused on general science, NASA, and the intersection between technology and society, Greenfieldboyce has been on the science desk's technology beat since she joined NPR in 2005.

In that time Greenfieldboyce has reported on topics including the narwhals in Greenland, the ending of the space shuttle program, and the reasons why independent truckers don't want electronic tracking in their cabs.

Much of Greenfieldboyce's reporting reflects an interest in discovering how applied science and technology connects with people and culture. She has worked on stories spanning issues such as pet cloning, gene therapy, ballistics, and federal regulation of new technology.

Prior to NPR, Greenfieldboyce spent a decade working in print, mostly magazines including U.S. News & World Report and New Scientist.

A graduate of Johns Hopkins, earning her Bachelor's of Arts degree in social sciences and a Master's of Arts degree in science writing, Greenfieldboyce taught science writing for four years at the university. She was honored for her talents with the Evert Clark/Seth Payne Award for Young Science Journalists.

Pages

Goats and Soda
12:53 pm
Fri September 5, 2014

The Latest Word From WHO On Experimental Ebola Therapies

Proteins and enzymes that will produce antibodies for the experimental Ebola drug ZMapp are developed on the leaves of the nicotiana benthamiana plant, a relative of tobacco. Here, indicator proteins glow under ultraviolet light — a way to assess the success of bacteria spread.
Sean Gallup Getty Images

Originally published on Fri September 5, 2014 2:21 pm

One of the reasons Ebola is so terrifying is that there's no vaccine and no cure. But the World Health Organization hopes to change that, with plans to quickly test experimental products during this outbreak.

By November, two promising vaccines will have been tested on people to see if they're safe, says Marie-Paule Kieny, assistant director-general at WHO.

Read more
Goats and Soda
2:42 am
Thu August 21, 2014

How Much Bigger Is The Ebola Outbreak Than Official Reports Show?

Workers with the aid group Doctors Without Borders prepare a new Ebola treatment center near Monrovia, Liberia, on Sunday. The facility has 120 beds, making it the largest Ebola isolation clinic in history.
John Moore Getty Images

Originally published on Thu August 21, 2014 2:05 pm

The latest numbers on the Ebola outbreak are grim: 2,473 people infected and 1,350 deaths.

That's the World Health Organization's official tally of confirmed, probable and suspect cases across Guinea, Liberia, Sierra Leone and Nigeria. But the WHO has previously warned that its official figures may "vastly underestimate the magnitude of the outbreak."

So how bad is it really?

Read more
Shots - Health News
4:58 pm
Thu August 14, 2014

A Virtual Outbreak Offers Hints Of Ebola's Future

Kenyan health officials take the temperatures of passengers arriving at the Nairobi airport on Thursday. Kenya has no reported cases of Ebola, but it's a transportation hub and so is on alert.
Simon Maina AFP/Getty Images

Originally published on Thu August 14, 2014 7:07 pm

While the Ebola outbreak continues to rage in West Africa, it is also unfolding — in a virtual sense — inside the computers of researchers who study the dynamics of epidemics.

Policymakers look to these simulations to get a sense of how the outbreak might spread. They also can use them to run experiments to see which public health measures should take priority.

Read more
Shots - Health News
2:25 am
Wed August 13, 2014

Biologists Choose Sides In Safety Debate Over Lab-Made Pathogens

An outbreak of bird flu in India in 2008 prompted authorities to temporarily ban the sale of poultry.
Diptendu Dutta AFP/Getty Images

Originally published on Thu August 14, 2014 4:23 pm

A smoldering debate about whether researchers should ever deliberately create superflu strains and other risky germs in the interest of science has flared once again.

Read more
Global Health
3:19 pm
Tue August 12, 2014

Ethics Panel Endorses The Use Of Experimental Drugs To Slow Ebola

Originally published on Tue August 12, 2014 8:53 pm

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Pages